KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Texas Instruments (TXN) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Texas Instruments (TXN) over the last 17 years, with Q4 2025 value amounting to $3.2 billion.

  • Texas Instruments' Cash & Equivalents rose 78.12% to $3.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.2 billion, marking a year-over-year increase of 78.12%. This contributed to the annual value of $3.2 billion for FY2025, which is 78.12% up from last year.
  • Latest data reveals that Texas Instruments reported Cash & Equivalents of $3.2 billion as of Q4 2025, which was up 78.12% from $3.3 billion recorded in Q3 2025.
  • Texas Instruments' Cash & Equivalents' 5-year high stood at $5.7 billion during Q3 2021, with a 5-year trough of $2.4 billion in Q1 2021.
  • In the last 5 years, Texas Instruments' Cash & Equivalents had a median value of $3.2 billion in 2022 and averaged $3.3 billion.
  • Per our database at Business Quant, Texas Instruments' Cash & Equivalents surged by 10067.33% in 2021 and then crashed by 4453.88% in 2024.
  • Quarter analysis of 5 years shows Texas Instruments' Cash & Equivalents stood at $4.6 billion in 2021, then tumbled by 34.14% to $3.1 billion in 2022, then fell by 2.82% to $3.0 billion in 2023, then rose by 7.96% to $3.2 billion in 2024, then rose by 0.78% to $3.2 billion in 2025.
  • Its Cash & Equivalents stands at $3.2 billion for Q4 2025, versus $3.3 billion for Q3 2025 and $3.0 billion for Q2 2025.